Evidence map›Paper›PMID 40458486›Full record

ArticleFrontiers in neuroscience2025

Alzheimer's disease recognition via long-range state space model using multi-modal brain images.

Ziyin Ren, Meng Zhou, Sadia Shakil, Raymond Kai-Yu Tong

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ziyin RenDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Meng ZhouDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Sadia ShakilDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Raymond Kai-Yu TongDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a persistent neurodegenerative abnormality, Alzheimer's disease (AD) is affecting an increasing number of elderly people. The early identification of AD is critical for halting the disease progression at an early stage. However, the extraction and fusion of multi-modal features at different scales from brain images remains a challenge for effective AD recognition. In this work, a novel feature fusion long-range state space model (FF-LSSM) model is suggested for effective extraction and fusion of multi-level characteristics from scannings of MRI and PET. The FF-LSSM can extract whole-volume features at every scale and effectively decide their global dependencies via adopted 3D Mamba encoders. Moreover, a feature fusion block is employed to consolidate features of different levels extracted by each encoder to generate fused feature maps. A classifier is cascaded at the end, using the fused features to produce the predicted labels. The FF-LSSM model is optimized and evaluated using brain images of subjects from the ADNI dataset. The inference result on the testing set reveals the FF-LSSM accomplishes a classification ACC of 93.59% in CN vs. AD and 79.31% in sMCI vs. pMCI task, proving its effectiveness in disease classification. Finally, the introduction of the Grad-CAM method illustrates that the implied FF-LSSM can detect AD- and MCI-related brain regions effectively.

Indexed as

Alzheimer's diseaselong-range sequential modelingmild cognitive impairmentmulti-modal brain imagesmulti-modality integration

Identifiers

PMID40458486
PMCPMC12127407

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.